SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is under pressure as traders debate the boards investigation into CEO Jensen Huang following reports of an affair with a woman suspected of ties to China, with some fearing national-security scrutiny or Huangs departure while others see the controversy as overblown. The community is split between continued selling and buying the dip ahead of earnings, with some also pointing to broader tech weakness.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

A disappointing Q3 reportwith a surprise loss, squeezed margins, weaker-than-expected outlook and a sequential subscriber declinehas driven a sharp selloff. Traders are split between concerns about profitability and execution and hopes that international growth, the Lilly partnership and the planned Peptides+ launch can support a recovery.

Digital Turbine, Inc. engages in mobile growth platform solutions for advertisers, publishers, carriers, and device original equipment manufacturers. It operates through the following segments: On Device Solutions and App Growth Platform. The On Device Solutions segment consists of products and services that simplify the discovery and delivery of mobile apps and content media for device end users. The App Growth Platform segment provides Advertising Solutions and Ad Monetization Solutions. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbines quarterly results triggered a sharp selloff despite revenue growth and a higher sales outlook, as gross-margin compression and unchanged profit guidance raised concerns about whether growth is translating into earnings. Traders are divided between viewing the drop as an overreaction and worrying that margin pressure and debt could weigh on the turnaround.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

A third-quarter earnings beat, stronger-than-expected Q4 guidance, and an expanded buyback authorization sparked a sharp rally that quickly faded as traders weighed managements cautious tone and slowing underlying growth. Bulls see progress toward a turnaround, while skeptics point to declining year-over-year revenue, temporary revenue tailwinds, and doubts about management; the result has been intense debate over whether the report signals recovery or a sell-the-news move.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,203,846.69715353. The last known price of Ethereum is 2,121.02700944 USD and is down -0.91 over the last 24 hours. It is currently trading on 14303 active market(s) with $13,174,532,202.61 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is drawing attention amid a broad crypto selloff, with traders pointing to hot inflation data, increased Fed rate-hike bets, and leveraged long liquidations as sources of pressure. The discussion is largely bearish, with calls for further losses and concern about support, while some traders are buying the dip and looking for a reversal.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.09792366 USD and is down -1.80 over the last 24 hours. It is currently trading on 1894 active market(s) with $2,759,095,442.76 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is under pressure amid a broader crypto selloff, with traders citing Bitcoin weakness, inflation concerns and leveraged-position liquidations as factors behind the decline. The community is divided between bearish calls for further losses and dip-buying bulls pointing to oversold conditions and reported whale accumulation, while many question XRPs utility and Ripples token economics.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors pending FDA decision on deramiocel is the dominant focus, with traders centering on the November 22 decision and the amended applications upper-limb-function case for Duchenne muscular dystrophy. Many are optimistic about approval and a potential short squeeze, while others stress the binary risk and FDA skepticism; the AHA award for cardiac research adds to bullish sentiment but does not resolve the regulatory uncertainty.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARAs quarterly report has focused attention on its AI/HPC pivot: traders welcomed debt reduction, a share-repurchase authorization and an initial GPU-services contract, while noting that larger AI tenant leases remain unannounced. Reactions are split over whether the pivot can diversify the business, with skeptics emphasizing the revenue miss, Bitcoin-price exposure and execution risks.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics Q3 results and higher full-year revenue guidance, driven by continued BRIUMVI growth, are the main focus. Traders largely view the business update positively despite an initial selloff and sharp reversal; many are watching the upcoming subcutaneous BRIUMVI Phase 3 readout, while buyout and short-squeeze talk remains speculative.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Labs quarterly results are driving discussion: revenue and backlog growth beat expectations, but a wider-than-expected loss and Neutrons first launch being pushed to 2027 weighed on shares. Traders are split between viewing the loss as largely tied to Iridium-related costs and seeing the Neutron delay and profitability as key risks.

statis crypto Watchlist

Bitcoin

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BW ‘Repurchased $38 million in shares during the quarter’ … probably used up the remaining $12M this Qtr… even though Bryant garbage CEO for his own company $RILY , it wouldn’t surprise me if he pushes $BW to do another $50M buyback at EOY when they do the BOD mtg

StockTwits for iOS

Babcock & Wilcox Enterprises Inc

B. Riley Financial Inc

 ‘Repurchased $38 million in shares during the quarter’ … probably used up the remaining $12M this Qtr… even though Bryant garbage CEO for his own company 

 , it wouldn’t surprise me if he pushes 

 to do another $50M buyback at EOY when they do the BOD mtg

Tom Harrison

@PittsburghTrader they don&#39;t get it build the business and hire  a PRguy

StockTwits For Android 

 they don't get it build the business and hire  a PRguy